eli lilly retatrutide study Lilly's triple agonist hits 28.3% mean weight loss in TRIUMPH-1 phase 3, blowing past tirzepatide benchmarks & rewriting obesity math for payers, PBMs & the Novo Duopoly Big developments in the world

Fatty liver disease is a condition where fat accumulates in the liver, leading to inflammation and potential damage to the liver cells

It works best next to real changes in how you eat and move, and results vary from one person to the next

To minimize discomfort, try eating smaller, low-fat meals and drinking plenty of water

The exact phrase leaky gut is not usually found in the medical literature, though it is used to describe the process increased permeability of the intestinal barrier

doi:10.1038/nrn3880 167

So, Wegovy is a single-action medication that mimics one hormone in the body, while Zepbound has a dual function mimicking two hormones in the body that support blood glucose levels and weight loss